BIOPHARM FORWARD ApS: Financial statements 2020
CVR: 32438784
Source: annual report 2020, Danish Business Authority
26/08/2019 – 25/08/2020
BIOPHARM FORWARD ApS (CVR 32438784) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 181,875 and a net result of DKK 145,891 compared with DKK 201,331 the year before. That is a decrease of 37.6% compared with the year before. Equity in the 2020 report amounted to DKK 209,120. The solvency ratio was 37.8%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 181,875
- Profit/Loss
- DKK 145,891
- Equity
- DKK 209,120
- Total Assets
- DKK 553,670
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 182 t. | 146 t. | 209 t. | 1 |
| 2019 | - | 291 t. | 201 t. | 171 t. | 0 |
| 2018 | - | -2 t. | -2 t. | -30 t. | - |
| 2017 | - | -2 t. | -2 t. | -28 t. | - |
| 2016 | - | -1 t. | -1 t. | -26 t. | - |
Official annual report
How creditworthy is BIOPHARM FORWARD ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
BIOPHARM FORWARD ApS has published its annual report for 2019. Gross profit came to DKK 291,460, and the net result was DKK 201,331.
About BIOPHARM FORWARD ApS
BIOPHARM FORWARD ApS is a Danish company of the type Anpartsselskab based in Espergærde, founded in 2009. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Jonas Hink. The company is owned by Jonas Hink. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK 997,234 and a net result of DKK 243,660 compared with DKK 385,061 the year before. Equity in the 2025 report amounted to DKK 1,741,315.